24小时热门版块排行榜    

查看: 169  |  回复: 2
当前主题已经存档。
【悬赏金币】回答本帖问题,作者alicew将赠送您 40 个金币

alicew

铜虫 (正式写手)

[求助] 求4个上市抗癌药物的IC50值

Currently there are four organic intercalators approved by the FDA for the treatment of human cancers:

1:
Daunorubicin (sold under the brand names of Cerubidine® and Daunoxone® and the generic name Daunorubicin hydrochloride)

2:
Doxorubicin (sold under the brand name Adriamycin PFS®, Adriamycin RDF®, Rubex® and the generic name Doxorubicin hydrochloride)

3:
Mitoxantrone (sold under the brand name Novanthrone ® and its generic name)

4:
Amsacrine

求上面4个化合物的对P388和A549两个细胞的IC50值。

请给出具体数值,和文献。万分感谢!

» 猜你喜欢

已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

13073456851

金虫 (正式写手)

文献摘要一个:
Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug—resistant cell line SMMC—7721/R
摘 要:AIM:To investigate the correlation between subcellular daunorubicin distribution and the multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R.METHODS:The multidrug resistant cell line SMMC-7721/R,a human hepatocellular carcinoma cell line,was established.Antisenes oligonucleotides(AS-ODN)were used to obtain different multidrug resistance phenotypes by inhibiting the expression of mdr1 gene and/or multidrug resistance-related protein gene(mrp)using Lipofectamine as delivery agent.Expression of mdr1 and mrp genes was evaluated by RT-PCRand Western blotting.Intracellular daunorubicn(DNR)concentration was measured by flow cytometry.Subcellular DNR distribution was analyzed by confocal laser scanning microscopy.Adriamycin(ADM)and DNR sensitivity was examined by MTTmethod.RESULTS:Low level expression of mdr1 and mrpmRNAs and no expression of P-Glycoprotein(P-gp)and multidrug resistance-related protein(P190)were detected in parental sensitive cells SMMC-7721/S,but over-expression of these two genes was observed in drug-resistant cell SMMC-7721/R,The expression of mdr1 and mrp genes in SMMC-7721/Rcells was down-regulated to the level in the SMMC-7721/Scells by AS-ODN.Intracellular DNAconcentration in SMMC-7721/Scells was 10times higher than that in SMMC-7721/Rcells.In SMMC7721/Scells intracellular DNA distributed evenly in the nucleus and cytoplasm.while in SMMC-7721/Rcells DNR distributed in a punctate pattern in the cytoplasm and was reduced in the nucleus.DNR concentration in SMMC-7721/Rcells co-transfected with AS-ODNs targeting to mdr1and rpmRNAs recovered to 25percent of that in SMMC7721/Scells.Intracellular DNA distribution pattern in drug-resistant cells treated by AS-ODN was similar to drug-sensitive cell.and the cells resistance index(RI)to DNA and AMD decreased at most from 88.0and 116.0to4.0and 2.3,repectively.Co-Transfection of two AS-ODNs showed a stronger synergistic effect than separate transfection.CONCLUSIONS-gp and P190are two members mediatingMDR in cellline SMMC7721/R,Intracellular drug concentration increase and subcellular distribution change are two important factos in multidrug resistance(MDR)formation.The second facto,drugs transport by P-gp andP190from cell nucleus to organell in cytoplasm,may play a more important role.
子非鱼,焉知鱼之乐?
2楼2007-07-18 17:03:13
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

13073456851

金虫 (正式写手)

SOMATOSTATIN MAY ENHANCE CYTOTOXIC EFFECT OF DOXORUBICIN ON GALLBLADDER CANCER CELLS李济宇[1] 全志伟[1] 张强[2] 刘建文[2][1]DepartmentofGeneralSurgery,XinhuaHospital,ShanghaiSecondMedicalUniversity,Shanghai200092 [2]StateKeyLaboratoryofBioreactorEngineering,NewWorldInstituteofBiotechnology,EastChinaUniversityofScienceandTechnology,Shanghai200237摘 要:Objective: To explore the change of chemosensitivity of gallbladder cancer cells pre-treated with somatostatin. Methods: Twenty-four hours after somatostatin treatment, gradient concentrated Doxorubicin was added and growth curve of gallbladder cancer cells was investigated to measure IC50, i.e.,concentration of l)oxorubicin at 50% cell viability.Results: Somatostatin ccould induce gallbladder cancer cell growth arrest in S phase. Inhibition of growth of cancer cell line was detected by Doxorubicin concentration- dependently (P<0.05). IC50 value was significantly lower by combined-treating with somatostatin and Doxorubicin compared with by Doxorubicin alone (P<0.05). Conclusion: Somatostatin could increase the cytotoxic effect of Doxorubicin on gallbladder cancer cell by modulating its cell cycle.

关键词:生长激素抑制素 增强作用 细胞毒素 阿霉素 胆囊癌 癌细胞 消化系统
分类号: R735.8文献标识码:文章编号:栏目信息:Articles
相关文献:主题相关
子非鱼,焉知鱼之乐?
3楼2007-07-18 17:04:59
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 alicew 的主题更新
不应助 确定回帖应助 (注意:应助才可能被奖励,但不允许灌水,必须填写15个字符以上)
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[考研] 299求调剂 +6 某某某某位 2026-03-21 6/300 2026-03-24 12:22 by 544594351
[考研] 327求调剂 +5 prayer13 2026-03-23 5/250 2026-03-23 22:11 by 星空星月
[考研] 一志愿211 初试270分 求调剂 +4 谷雨上岸 2026-03-23 5/250 2026-03-23 21:18 by 不惑可乐
[考研] 一志愿武理材料工程348求调剂 +6  ̄^ ̄゜汗 2026-03-19 9/450 2026-03-23 19:53 by pswait
[考研] 333求调剂 +3 ALULU4408 2026-03-23 3/150 2026-03-23 19:04 by macy2011
[考研] 一志愿上海交大生物与医药专硕324分,求调剂 +5 jiajunX 2026-03-22 5/250 2026-03-23 18:07 by YMU施老师
[考研] 333求调剂 +6 87639 2026-03-21 10/500 2026-03-23 10:41 by Iveryant
[考研] 一志愿 西北大学 ,070300化学学硕,总分287,双非一本,求调剂。 +3 晨昏线与星海 2026-03-20 3/150 2026-03-22 16:00 by ColorlessPI
[考研] 285求调剂 +6 ytter 2026-03-22 6/300 2026-03-22 12:09 by 星空星月
[考研] 材料学硕301分求调剂 +7 Liyouyumairs 2026-03-21 7/350 2026-03-21 22:31 by peike
[考研] 化学求调剂 +4 临泽境llllll 2026-03-17 5/250 2026-03-21 02:23 by JourneyLucky
[考研] 332求调剂 +4 ydfyh 2026-03-17 4/200 2026-03-21 02:20 by JourneyLucky
[考研] 一志愿武汉理工材料工程专硕调剂 +9 Doleres 2026-03-19 9/450 2026-03-20 22:36 by JourneyLucky
[考研] 材料学硕297已过四六级求调剂推荐 +11 adaie 2026-03-19 11/550 2026-03-20 21:30 by laoshidan
[考研] 一志愿南理工085701环境302求调剂院校 +3 葵梓卫队 2026-03-20 3/150 2026-03-20 19:28 by zhukairuo
[考研] 086500 325 求调剂 +3 领带小熊 2026-03-19 3/150 2026-03-20 18:38 by 尽舜尧1
[考研] 生物学调剂招人!!! +3 山海天岚 2026-03-17 4/200 2026-03-19 21:34 by 怎么释怀
[考研] 085600材料与化工调剂 324分 +10 llllkkkhh 2026-03-18 12/600 2026-03-19 14:33 by llllkkkhh
[考研] 材料考研调剂 +3 xwt。 2026-03-19 3/150 2026-03-19 11:22 by w沐阳w
[考研] 本科郑州大学物理学院,一志愿华科070200学硕,346求调剂 +4 我不是一根葱 2026-03-18 4/200 2026-03-19 09:11 by 浮云166
信息提示
请填处理意见